Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Response Biomed Corp RPBIF

Healthcare Diagnostics & Research
"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Response Biomed Corp
Bullboard Posts
User Avatar Image
(2)
•••
Comment by dimar66on Nov 02, 2010 4:44pm
297 Views
Post# 17647385

RE: DR Holler ONE QUESTION - please !!!!

RE: DR Holler ONE QUESTION - please !!!!
WHY wasn't Kaye let go after the 1st Quarter loss of 1st year


What you are saying is that Tony Holler and co. haven't been taking care of business and I agree, guess we thought that because they did good with ID Biomedical, they knew what they were doing; but it could be that their success there was because they were lucky enough to have some outstanding employees.  I think Q3 should be good because we should be seeing results from the Chinese expansion and all other things being equal this will be an overall benefit for the bottom line.  Orbimed is showing they are able todo what is necesaary and this to me is encouraging.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities